The Role of ABO Blood Type in Patients with SARS-CoV-2 Infection: A Systematic Review

The SARS-CoV-2 infection has caused over 422 million contagions and 5.8 million deaths resulting in a global health crisis. Several studies have investigated the risk factors predisposing to the infection and reported that the host susceptibility can be linked to the ABO blood group, but the current evidence is controversial. We systematically searched for articles in EMBASE, PubMed, and Cochrane library published up to 7 May 2021 to explore the association of the ABO blood group with the susceptibility to SARS-CoV-2 infection. All studies in people undergoing SARS-CoV-2 test controls were included. Odds ratios were obtained in each study and then synthesised by using meta-analysis. Overall, 22 articles were selected and more than 1,200,000 individuals of whom 74,563 resulted positive to SARS-CoV-2 and 1,166,717 resulted negative, were included in the meta-analysis. Overall, 487,985 subjects had blood group A, 151,879 had group B, 52,621 had group AB, and 548,795 had group O. Group O was slightly less associated with infection, as compared to the other three blood groups (OR = 0.91, 95% CI = 0.85–0.99, <i<p</i< = 0.02). Conversely, group A was slightly more associated with infection, as compared to the other three groups (OR = 1.06, 95% CI = 1.00–1.13, <i<p</i< = 0.04). This meta-analysis shows associations between blood groups and SARS-CoV-2 infection and supports the hypothesis that blood type O may have a slightly lower risk of infection, whereas blood type A may have a slightly higher risk of infection..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Journal of Clinical Medicine - 11(2022), 11, p 3029

Sprache:

Englisch

Beteiligte Personen:

Federico Banchelli [VerfasserIn]
Pierpaolo Negro [VerfasserIn]
Marcello Guido [VerfasserIn]
Roberto D’Amico [VerfasserIn]
Veronica Andrea Fittipaldo [VerfasserIn]
Pierfrancesco Grima [VerfasserIn]
Antonella Zizza [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.mdpi.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

ABO blood group
COVID-19
Coronavirus disease 2019
Medicine
R
SARS-CoV-2 infection
Susceptibility
Systematic review

doi:

10.3390/jcm11113029

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ041919521